HIZITECH Trademark

Trademark Overview


On Tuesday, July 30, 2024, a trademark application was filed for HIZITECH with the United States Patent and Trademark Office. The USPTO has given the HIZITECH trademark a serial number of 98673807. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, February 11, 2025. This trademark is owned by Guangzhou Zilong Technology Co., Ltd. The HIZITECH trademark is filed in the Medical Instrument Products category with the following description:

Shockwave therapy machine, used to relieve back muscle pain
hizitech

General Information


Serial Number98673807
Word MarkHIZITECH
Filing DateTuesday, July 30, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, February 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesShockwave therapy machine, used to relieve back muscle pain
Translation of Words in MarkThe wording Hizitech has no meaning in a foreign language.

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2024
Primary Code010
First Use Anywhere DateFriday, May 3, 2024
First Use In Commerce DateFriday, May 3, 2024

Trademark Owner History


Party NameGuangzhou Zilong Technology Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHuadu Guangzhou 510000
CN

Trademark Events


Event DateEvent Description
Tuesday, July 30, 2024NEW APPLICATION ENTERED
Thursday, January 16, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 6, 2025ASSIGNED TO EXAMINER
Tuesday, February 11, 2025NON-FINAL ACTION E-MAILED
Tuesday, February 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 11, 2025NON-FINAL ACTION WRITTEN